Literature DB >> 8634264

Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor.

B Vannier1, H Loosfelt, G Meduri, C Pichon, E Milgrom.   

Abstract

The extracellular domain of the human FSH receptor was expressed in Escherichia coli as a fusion protein with ubiquitin. It was tagged with a poly-His tract which was used for its purification. Immunization of mice allowed the preparation of high affinity antireceptor monoclonal antibodies. The latter fell into two categories: some of them were inhibited hormone binding and adenylate cyclase activation whereas others were devoid of these properties. None of the antibodies had agonistic activity (i.e., stimulated adenylate cyclase). Immunoaffinity chromatography allowed us to purify the native receptor in a single step either from a permanently transfected L cell line (75% recovery) or from human ovaries (33% recovery). Immunoblotting of the receptor in human ovaries showed the presence of a major band of 87 kDa and of a minor band of 81 kDa. Endoglycosidase digestion and pulse-chase experiments showed the former to be the mature receptor and the latter the precursor containing mannose-rich carbohydrates. Thus, as in the case for the LH receptor, there was an accumulation (albeit to a lower degree) of the precursor in target cells. We did not detect variant forms of the protein corresponding to the alternative mRNA transcripts previously described. Additive binding to the receptor of several antibodies, but not of the same antibody, allowed us to establish a sandwich-type ELISA for the receptor (sensitivity approximately 1 fmol) and to obtain evidence against the existence of previously described oligomeric forms of the protein. All monoclonal antibodies were able to label the receptor immunocytochemically in transfected cells, and two of them were also able to detect it at the markedly lower physiological concentrations, i.e., in human Sertoli and granulosa cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634264     DOI: 10.1021/bi952290f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Adenosine A2A receptor is involved in cell surface expression of A2B receptor.

Authors:  Kengo Moriyama; Michail V Sitkovsky
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 2.  FSH Actions and Pregnancy: Looking Beyond Ovarian FSH Receptors.

Authors:  Julie A W Stilley; Deborah L Segaloff
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

Review 3.  Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?

Authors:  Konstantinos Papadimitriou; Panteleimon Kountourakis; Anastasia E Kottorou; Anna G Antonacopoulou; Christian Rolfo; Marc Peeters; Haralabos P Kalofonos
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

4.  Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.

Authors:  Alfredo Perales-Puchalt; Nikolaos Svoronos; Melanie R Rutkowski; Michael J Allegrezza; Amelia J Tesone; Kyle K Payne; Jayamanna Wickramasinghe; Jenny M Nguyen; Shane W O'Brien; Kiranmai Gumireddy; Qihong Huang; Mark G Cadungog; Denise C Connolly; Julia Tchou; Tyler J Curiel; Jose R Conejo-Garcia
Journal:  Clin Cancer Res       Date:  2016-07-19       Impact factor: 12.531

5.  Ectopic expression of FSH receptor isoforms in neoplastic but not in endothelial cells from pancreatic neuroendocrine tumors.

Authors:  C Sardella; D Russo; F Raggi; M Lombardi; C Urbani; S Brogioni; U Boggi; N Funel; B Chifenti; D Campani; G Fanelli; P Marchetti; F Basolo; M T Locci; E Martino; F Bogazzi
Journal:  J Endocrinol Invest       Date:  2012-06-25       Impact factor: 4.256

6.  Extragonadal FSH receptor: is it real?

Authors:  T Rajendra Kumar
Journal:  Biol Reprod       Date:  2014-08-20       Impact factor: 4.285

7.  PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging.

Authors:  Hao Hong; Yongjun Yan; Sixiang Shi; Stephen A Graves; Lazura K Krasteva; Robert J Nickles; Min Yang; Weibo Cai
Journal:  Mol Pharm       Date:  2015-01-20       Impact factor: 4.939

8.  Signaling through FSH receptors on human umbilical vein endothelial cells promotes angiogenesis.

Authors:  Julie A Stilley; Rongbin Guan; Diane M Duffy; Deborah L Segaloff
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

9.  Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development.

Authors:  Kahina Boukari; Geri Meduri; Sylvie Brailly-Tabard; Jean Guibourdenche; Maria Luisa Ciampi; Nathalie Massin; Laetitia Martinerie; Jean-Yves Picard; Rodolfo Rey; Marc Lombès; Jacques Young
Journal:  J Clin Endocrinol Metab       Date:  2009-03-10       Impact factor: 5.958

10.  Trafficking of the follitropin receptor.

Authors:  Alfredo Ulloa-Aguirre; James A Dias; George Bousfield; Ilpo Huhtaniemi; Eric Reiter
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.